Lehfilcon A contact lenses
DeviceInvestigational silicone hydrogel contact lenses
Other names: LID018869
NCT Number: NCT04178720
The purpose of this clinical study is to evaluate the safety and effectiveness of an investigational soft contact lens compared to a commercially available soft contact lens when worn for daily wear and replaced monthly.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Alcon Investigative Site, Longwood, Florida, United States
Subjects are expected to attend 6 study visits. The expected duration of study lens exposure is approximately 3 months.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Key Inclusion Criteria:
Key Exclusion Criteria:
Investigational silicone hydrogel contact lenses
Other names: LID018869
Commercially available silicone hydrogel contact lenses
Other names: CooperVision® BIOFINITY®, Biofinity
Hydrogen peroxide-based system for cleaning and disinfecting silicone hydrogel contact lenses
Other names: CLEAR CARE® Cleaning & Disinfecting Solution
Time frame: Dispense, Week 1 follow-up, Week 2 follow-up, Month 1 follow-up, Month 2 follow-up, Month 3 follow-up (at least 4 hours after lens insertion at each follow-up assessment visit)
Visual acuity (VA) was assessed for each eye individually with study lenses in place at a distance of 6 meters using a letter chart. VA was collected in Snellen and converted to logarithm minimum angle of resolution (logMAR). A logMAR value of 0 equates to 20/20 Snellen visual acuity (normal distance eyesight), with a lower logMAR value indicating better visual acuity. No formal hypothesis testing was planned.
Time frame: Dispense, Week 1 follow-up, Week 2 follow-up, Month 1 follow-up
Visual acuity (VA) was assessed for each eye individually with study lenses in place at a distance of 6 meters using a letter chart. VA was collected in Snellen and converted to logarithm minimum angle of resolution (logMAR). A logMAR value of 0 equates to 20/20 Snellen visual acuity (normal distance eyesight), with a lower logMAR value indicating better visual acuity. No formal hypothesis testing was planned.
Alcon Research
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07570602
Eye Diseases, Presbyopia
Bloomington, Indiana, United States
View Trial DetailsNCT07614113
Eye Diseases, Myopia
Faisalābad, Punjab Province, Pakistan
View Trial DetailsNCT06668246
Ametropia, Eye Diseases
Brest, France
View Trial DetailsNCT05059041
Abnormalities, Multiple, Chromosome Disorders
Columbus, Ohio, United States
View Trial Details